自新型冠状病毒在全球蔓延，为抗击新冠病毒肺炎，提高治愈率，降低死亡率，科学研究人员积极探索对抗新型冠状病毒的诊治方案，对恢复期患者的抗体水平进行了要求。
抗体作为免疫性疾病的血清学标志，对于疾病的早期预测、辅助诊断、预后评估、治疗监测等方面均有着重要的价值。抗体检测在临床已经有着非常成熟的应用，抗体检测对于各种疾病有着很高的诊断敏感性，因此被认为是疾病的首选筛查项目。同时一种抗体可出现在多种疾病中，一种疾病中可出现多种抗体。抗体的联合检测，既避免了疾病的漏诊，也避免了误诊的发生。
流式荧光发光法，是基于编码微球和流式技术的一种临床应用型高通量发光检测技术，又称悬浮阵列、液态芯片、液芯以及xMAP技术等。该技术有机整合了荧光编码微球、 激光检测、应用流体学、高速数字信号处理技术等多项技术，具有多指标联合检测、通量高、速度快、标本用量少、既能检测蛋白也能检测核酸等优点。
为了适应临床对于疾病病情评估和疗效观察的需要，流式荧光发光法可以有针对性的做一些亚组合抗体谱的检测，比如系统性红斑狼疮抗体谱（包含dsDNA、C1q、Nucleosome、
Histone、Ribosomal P、RNP、Sm、PCNA），除了互相补充、避免漏诊，而且还能早期预测狼疮肾炎的发生。
南京巴傲得生物科技有限公司 ( Biogot technology, co, Ltd），是专一服务于生命科学研究的专业技术型企业。是一大批志同道合的资深专业人士共同创办的具有现代化经营管理水平的生物高科技企业，从事生物技术产品的开发及销售，致力于将巴傲得生物打造成中国乃至世界一流的生物技术产品供应商。巴傲得生物长期备有Bioworld抗体现货8000多种抗体可以在一周左右送到客户的手里。精湛品质、合理价格、专业服务，是我们为您服务的宗旨。在细胞信号通路、免疫学、蛋白组学上拥有显著优势，其抗体产品、生长因子等为生命科学科研工作者提供了极大的便利。客户的满意、微笑和信任是对我们最大的鼓舞与激励，巴傲得生物愿以专业的知识、卓越的服务作为您事业腾飞的基石！
Since novel coronavirus spread all over the world, in order to fight against Covid-19 pneumonia, improve the cure rate and reduce the mortality rate, scientific researchers actively explored the diagnosis and treatment plan against novel coronavirus, and required the antibody level of convalescent patients.
Antibodies, as serological markers of immune diseases, have important value in early prediction, auxiliary diagnosis, prognosis evaluation and treatment monitoring of diseases. Antibody detection has been very mature in clinical application, and it has high diagnostic sensitivity for various diseases, so it is considered as the first
screening item for diseases. At the same time, one antibody can appear in many diseases, and many antibodies can appear in one disease. Combined detection of antibodies can avoid both missed diagnosis and misdiagnosis.
Flow fluorescence spectrometry is a clinical application high-throughput luminescence detection technology based on coded microspheres and flow technology, also known as suspension array, liquid chip, liquid core and xMAP technology. This technology organically integrates fluorescent coded microspheres, laser detection, applied fluidics, high-speed digital signal processing technology and other technologies, and has the advantages of multi-index joint detection, high flux, high speed, less sample consumption, and can detect both protein and nucleic acid.
In order to meet the clinical needs of disease evaluation and curative effect observation, flow fluorescence spectrometry can be targeted to detect some sub-combination antibody spectrum, such as antibody spectrum of systemic lupus erythematosus (including dsDNA, C1q, Nucleosome, Histone, Ribosomal P, RNP, Sm, PCNA), which can not only complement each other and avoid missed diagnosis, but also predict the occurrence of lupus nephritis early.
Bioworld technology co., Ltd manufactures and supplies antibodies for worldwide distribution. We provide antibodies in bulk quantity and OEM basic services. The experienced scientific and technical professionals make Bioworld Technology a highly innovative, first-class biotechnological company on both manufacturing and marketing. Bioworld strives for a national leader and the world-
class company in manufacturing biological products for industry, health, and research. We look forward to serving your research needs and becoming your long-term research partner.
新冠系列（含流式抗体） - 图文
